# Efficacy and Safety of PVT-1 Treatment in Patients With Advanced Non-Small Cell Lung Cancer

> **NCT04840004** · PHASE2 · UNKNOWN · sponsor: **PlusVitech S.L.** · enrollment: 24 (estimated)

## Conditions studied

- Non Small Cell Lung Cancer
- Advanced Cancer
- Refractory Cancer

## Interventions

- **DRUG:** PVT-1

## Key facts

- **NCT ID:** NCT04840004
- **Lead sponsor:** PlusVitech S.L.
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-03-10
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2023-04-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04840004

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04840004, "Efficacy and Safety of PVT-1 Treatment in Patients With Advanced Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04840004. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*